Preferred Label : mechlorethamine;

MeSH definition : A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA.;

MeSH synonym : chlormethine; mustine; nitrogen mustard; chlorethazine; bis(2-chloroethyl)methylamine; methylchlorethamine;

CISMeF synonym : 55-86-7 (Mechlorethamine hydrochloride); N-Oxide, mechlorethamine; genopharm brand of mechlorethamine hydrochloride; oxide, mechlorethamine; merck brand of mechlorethamine hydrochloride; merck frosst brand of mechlorethamine hydrochloride;

MeSH hyponym : NSC-10107; embichin; mustargen; nitrogranulogen; cloramin; mechlorethamine N-Oxide; caryolysine; NSC-762; mitomen; mechlorethamine hydrochloride N-Oxide; nitromin; mechlorethamine oxide; mechlorethamine hydrochloride; Hydrochloride, Mechlorethamine; Hydrochloride N-Oxide, Mechlorethamine; Mechlorethamine Hydrochloride N Oxide; N-Oxide, Mechlorethamine Hydrochloride; NSC 762; NSC762; NSC 10107; NSC10107; Mechlorethamine N Oxide; Nitrogen Mustard N-Oxide; N-Oxide, Nitrogen Mustard; Nitrogen Mustard N Oxide;

MeSH CAS label : ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-;

MeSH Related Number : mechlorethamine hydrochloride; mechlorethamine hydrochloride N-Oxide; mechlorethamine N-Oxide; 126-85-2 (N-oxide); 302-70-5 (N-oxide, HCl); 55-86-7 (HCl); L0MR697HHI; 51-75-2;

Registry Number MeSH : 51-75-2;

Related CAS MeSH : 302-70-5 (Mechlorethamine hydrochloride N-Oxide); 126-85-2 (Mechlorethamine N-Oxide); L0MR697HHI (Mechlorethamine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Bis(2-chloroethyl)methylamine;

Codes EINECS : 200-120-5;

Is substance : O;

UNII : 50D9XSG0VR;

Details


Main resources

You can consult :

A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA.

https://ansm.sante.fr/tableau-atu-rtu/ledaga-160-microgrammes-g-gel
2017
false
false
false
France
French
guidelines for drug use
administration, cutaneous
gels
mechlorethamine
mycosis fungoides
package leaflet
summary of product characteristics
chlormethine
adult
aged
antineoplastic agents, alkylating
continuity of patient care
drug prescriptions
pharmacovigilance
professional role
drug monitoring

---
https://www.ema.europa.eu/medicines/human/EPAR/Ledaga
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
mechlorethamine
orphan drug production
drug approval
europe
mycosis fungoides
adult
antineoplastic agents, alkylating
antineoplastic agents, alkylating
administration, cutaneous
gels
mechlorethamine hydrochloride
mechlorethamine hydrochloride
chlormethine
aged
pregnancy
breast feeding
drug evaluation, preclinical
treatment outcome
mechlorethamine

---
https://www.has-sante.fr/portail/jcms/c_2794001/fr/ledaga
https://www.has-sante.fr/portail/jcms/c_2794001/fr/ledaga-chlormethine-alkylant
2017
false
false
false
France
French
orphan drug production
mycosis fungoides
adult
antineoplastic agents, alkylating
administration, cutaneous
gels
mechlorethamine hydrochloride
chlormethine
aged
treatment outcome
evaluation of the transparency committee
quality of life
mechlorethamine hydrochloride
antineoplastic agents, alkylating
guidelines for drug use
mechlorethamine
mechlorethamine

---
http://www.has-sante.fr/portail/jcms/c_1118231/caryolysine-chlormethine-alkylant-en-application-cutanee-synthese-d-avis
2011
France
French
guidelines for drug use
evaluation of the transparency committee
mechlorethamine
antineoplastic agents, alkylating
chlormethine
administration, cutaneous
mycosis fungoides
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1062709/caryolysine
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/caryolysine_-_ct-_9861.pdf
2011
France
French
evaluation of the transparency committee
mechlorethamine
antineoplastic agents, alkylating
chlormethine
treatment outcome
mycosis fungoides
administration, cutaneous

---
http://www.aboutkidshealth.ca/en/healthaz/drugs/pages/mechlorethamine.aspx?k=m%c3%a9chlor%c3%a9thamine;+m%c3%a9dicaments+utilis%c3%a9s+dans+le+cadre+d%e2%80%99une+chimioth%c3%a9rapie
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Mechlorethamine.aspx
2010
Canada
French
English
antineoplastic agents, alkylating
child
mechlorethamine
mechlorethamine
antineoplastic agents, alkylating
chlormethine
injections, intravenous
drug information
patient education handout

---
http://www.meddispar.fr/medicaments/3019129
2008
France
French
injections
drug prescriptions
mechlorethamine
administration, cutaneous
legislation, drug
continuity of patient care
drug monitoring
chlormethine
drug information

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032580.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400999
2006
France
French
mechlorethamine
administration, cutaneous
infusions, intravenous
antineoplastic agents, alkylating
chlormethine
insurance, health, reimbursement
hodgkin disease
psoriasis
mycosis fungoides
treatment outcome
adult
evaluation of the transparency committee

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.